RCM
EBACW

Radcliffe Capital Management’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Radcliffe Capital Management’s Portfolio EBACW Stock Details EBACW Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
2022
Q4 		$672K Sell
2022
Q3 		$661K Hold
2022
Q2 		$653K Hold
2022
Q1 		$651K Hold
2021
Q4 		$647K Hold
2021
Q3 		$649K Hold
2021
Q2 		$647K Buy